Health & Personal Care
HIGH
FDA DRUG
Ascend Laboratories Recalls ARIPIPRAZOLE 10 mg Tablets Over Superpotent Drug Risks (2025)
ARIPIPRAZOLE
Superpotent drug
1,320 recalls tagged with “fda regulated”.
Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil
Potential contamination with Listeria monocytogenes
Potential contamination with Listeria monocytogenes
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.